GlassScriptPhysician profile
Robert C Hayden
NPI 1215499389
$1,226.51
in general payments reported to CMS, 2019-2025
14 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2022: $35.64 · 2023: $561 · 2024: $320 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $250.25 | 2023-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.05 | 2023-2024 | Jardiance |
| Aimmune Therapeutics, INC. | $128.86 | 2023-2025 | Vowst |
| Glaxosmithkline, LLC. | $124.61 | 2020 | |
| Janssen Pharmaceuticals, INC | $113.87 | 2022-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $88.66 | 2022-2024 | Wainua, Lokelma |
| Novartis Pharmaceuticals Corporation | $80.17 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $67.70 | 2024-2025 | Verquvo |
| Abbvie INC. | $67.13 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $33.80 | 2023 | Ultomiris |
| Boston Scientific Corporation | $21.53 | 2025 | Watchman Flx |
| Pfizer INC. | $21.50 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $16.10 | 2024 | Inpefa |
| Medtronic, INC. | $14.28 | 2024 | Kyphon Express II Kyphopak Tray |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hayden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.